Lipase Market Size Analysis
According to a recent survey conducted by ChemView Consulting, the Global Lipase Market grew at a CAGR of 5.2% between 2017-2021 and is estimated to be US$ 802.3 Mn in 2022. Currently, the market is anticipated to grow at a CAGR of 6.0% and is expected to reach a valuation of US$ 1,436.8 Mn by 2032 end.
Besides helping with digestion, the pancreatic enzyme lipase also facilitates the movement of dietary fats throughout the body. This could result in a rise in lipase demand over the anticipated period. The lipase market is anticipated to grow significantly throughout the projected period due to several variables, including an exponential increase in digestive issues and expanded application possibilities across industries.
THE NEED TO CURB THE WIDESPREAD OF ILLNESS CONTRIBUTE TO THE GROWTH OF THE GLOBAL LIPASE MARKET
Consuming fatty foods and foods high in carbohydrates has been linked to increased health problems such as indigestion, bloating, and stomach pain. Global demand for lipase has increased due to the growing need to limit the spread of these illnesses.
The prevalence of high triglyceride levels, obesity, cholesterol, celiac disease, and other conditions continues to support the expansion of the global lipase market. Due to its numerous advantages, including improved texture, flavor, and shelf life, lipase is increasingly in demand in the food sector.
LACK OF TRANSPARENCY IN THE LAW OF PATENT PROTECTION WILL CREATE CHALLENGES IN THE LIPASE MARKET GROWTH
The growth of the lipase market would face difficulties due to the lack of clarity in patent protection rules. The technological infrastructure for food processing in developing and middle-income countries is inadequate, slowing the market’s expansion even more. The market growth rate will be hampered by poor expenditure on research and development capabilities in this direction in low and medium-income economies.
RISING CONCERNS AND AWARENESS ABOUT ANIMAL HEALTH IS FOSTERING THE GROWTH OF THE LIPASE MARKET
The lipase market is expanding as people’s worries, and understanding about animal health are increasing. Population growth and rising meat consumption contribute to the need for lipase expansion. Lipase is used in food products to improve food quality by enhancing flavors, texture, and shelf life. Therefore, the food and beverage industry’s development will directly impact the lipase market’s growth. Lipase has a variety of health advantages that will spur market expansion.
Market Segments Covered in Report
By Region and Country:
What makes the microbial source of lipase the largest and fastest-growing segment in the lipase market?
Microbial lipases are the most prevalent and fastest-growing segment due to their application features’ versatility and mass production simplicity.
Due to their wide range of enzymatic properties and substrate selectivity, microbial lipases are very attractive for commercial applications.
Which is the largest end-use application in the lipase market?
The food industry is anticipated to hold the greatest market share for lipase based on end-use. The potential of these foods to support our ability to keep a healthy gut is the reason. These aid in enhancing metabolism.
One of the key functions of lipase is also thought to be the transport of dietary lipids in the body. In addition, they have proven successful in preserving a robust pancreas. All of these factors have compelled manufacturers who work in the food industry to use lipase.
The regions analyzed for the market include North America, Europe, Latin America, Asia Pacific, Middle East, and Africa.
With an increasing number of both foreign and domestic players, the worldwide lipase market is becoming increasingly fragmented. The active firms are expanding their production capacity and developing new products to seize a sizable share of the global market due to lipase’s broad usage across numerous end-use industries.
Some of the key developments that have taken place in the Lipase Market include the following:
A list of some of the key suppliers present in the market are:
Report Coverage and Highlights
|Historical data available for||2017-2021|
|Market analysis||USD Million for Value and Tons for Volume, and CAGR from 2022 to 2032|
|Key regions covered||North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa|
|Key countries covered||US, Canada, Brazil, Mexico, Germany, Italy, France, UK, Spain, Netherlands, Norway, Russia, China, Japan, South Korea, India, Indonesia, Thailand, Vietnam, Australia & New Zealand, Saudi Arabia, Turkey, UAE, South Africa, Nigeria, Egypt|
|Key segments covered||By Source, End-Use, Form, and Region|
|Customization scope||Available upon Request|
|Pricing and purchase options||Available upon Request|
Frequently Asked Questions
In the forecast period between 2022 and 2032, the market is expected to grow at a CAGR of 6.0%.
The prevalence of obesity, cholesterol, celiac disease, and high triglycerides further continues to contribute to the growth of the global lipase market
Major global Lipase Market players are Chr. Hansen Holdings A/S, Amano Enzymes Inc., Clerici-Sacco Group, Novozymes A/S, Renco New Zealand, Associated British Foods Plc, Sacco and Dohler, Koninklijke DSM N.V., Advanced Enzymes
Lack of transparency in the law of patent protection will create challenges in the lipase market growth
Europe is expected to account for the largest market revenue share in the Global Lipase market.
Let us Help you!
Facing issues finding the exact research to meet your business needs? Let us help you! One of our Research Executives will help you locate the research study that will answer your concerns.Speak to Analyst
Connect with Us!